The endovascular management of infra-renal aneurysms has become ubiquitous, however, the endovascular management of pararenal and thoracoabdominal aneurysms remains coveted. In the United States, multiple industry trials including off-the-shelf or custom-made devices (CMD) are currently studying the feasibility and durability of endograft implantation in the supra-renal aorta. These trials are occurring at select centers throughout the United States with a large portion of the population left without access to these specific devices. Physicians who seek to treat these aneurysms may choose to seek a physician-sponsored investigational device exemption (IDE) from the Food and Drug Administration (FDA) to perform institutional trials studying the outcomes of physician-modified endografts (PMEG), an alternative to industry-supplied off-the-shelf or CMD devices. However, the majority of these repairs are performed at centers without formal investigational protocols. This chapter describes the current options and techniques for managing complex aneurysms utilizing physician-modified endografts. We will also describe adjunctive techniques to facilitate these operations. Techniques such as in-situ fenestration and parallel grafts are noteworthy; however, with the utilization of patient-specific fenestrated grafts we believe these should be reserved for unique situations. It must be emphasized that currently these techniques are investigational in 2024, and we eagerly await approved FDA devices to manage this portion of the aorta. In the previous edition of this textbook, this chapter discussed industry-supplied CMD devices. At that time, and still now, most vascular surgeons did not have access to off-the-shelf or CMD devices, therefore, we have shifted the focus of the chapter to a practical approach discussing the methods to modify the grafts on your own to treat this complex disease process during emergencies and situations where no other surgical option is available.